Scott Hutton - 15 Jan 2026 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
President & CEO, Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton
Issuer symbol
BDSX
Transactions as of
15 Jan 2026
Net transactions value
-$7,905
Form type
4
Filing time
20 Jan 2026, 16:21:20 UTC
Previous filing
06 Jan 2026
Next filing
11 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hutton Scott President & CEO, Director 919 WEST DILLON RD, LOUISVILLE /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton 20 Jan 2026 0001697361

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +2,633 +7.1% 39,944 15 Jan 2026 Direct F1
transaction BDSX Common Stock Sale $7,905 -970 -2.4% $8.15 38,974 16 Jan 2026 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -2,633 -33% $0.000000 5,265 15 Jan 2026 Common Stock 2,633 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F3 The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
F5 These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.